Clinical trial of Umifenovir proves successful in treating COVID
India | Sep 15, 2021, 10:15 AM ISTThe trial of Umifenovir on 132 Covid patients showed that, if proper dose is given twice daily for five days, the drug can effectively reduce viral load to zero in mild or moderate symptomatic and asymptomatic patients by checking multiplication of the virus.